DHR
Danaher CorporationNYSEHealth CareDiagnostics & ResearchSnapshot 2026-05-08
As of May 8, 2026, DHR has a composite score of 13.4 and is labeled as "mild favorable." This score is influenced by a medium confidence level of 79.3 and a moderate risk label, with notable strengths in macro factors (31.5) and management (44.9). The analysis is provisional, reflecting potential changes in guidance and sector trends.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)0.17
- Bonus0.00
Why this rank
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Why this rank
Watch
— has something changed worth re-reading?Why this setup
EPS estimate $1.88 → $1.84 (-2.3% / 30d). 1 raised, 15 cut, 20 covering analysts.
0 upgrades, 0 downgrades / 30d, 8 maintained. 92% of analysts rate Buy.
4 PT revisions / 30d. Avg target 19.4% above current price.
1 positive, 1 negative / 30d. See F4 management tile for the event list.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
10 material events in the last 24 months — top 5 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Increase EPS guidancegrowthbehind10% progress
4/21: “The Company is increasing its full year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55.”
Why this status
Stated in 2 of last 2 quarters. EPS guidance increased from $7.70-$7.80 in 2025-Q4 to $8.35-$8.55 in 2026-Q1. The trajectory shows an upward revision in guidance, indicating progress towards this priority.
- 2.Grow core revenue 3% to 6%growthbehind10% progress
4/21: “The Company continues to expect that non-GAAP core revenue will increase in the 3% to 6% range year-over-year.”
Why this status
Stated in 3 of last 3 quarters. Revenue decreased from $6.09B in 2025-Q4 to $5.74B in 2026-Q1, indicating limited progress towards the 3% to 6% growth target. The recurring focus on this priority has yet to translate into substantive revenue growth.
- 3.Announce share buybackcapital allocationmixed40% progress
4/29: “Danaher announced a share buyback on April 29, 2026.”
Why this status
Newly stated in 2026-Q1. The announcement of a share buyback on April 29, 2026, marks a step in Danaher's capital allocation strategy. However, without specific buyback amounts or execution details, the impact remains to be seen.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 30%; 252d 29%.
Drawdown — Max 1y −29%. Bad day move −3%.
Beta to sector ETF (XLV) — 1.17 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 52/100, drawdown 42/100, beta 83/100, earnings vol —.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Increase EPS guidance
GrowthNew since 2026-05-04Danaher aims to increase its full year adjusted diluted net earnings per share guidance.
BehindStated in 2 of last 2 quarters. EPS guidance increased from $7.70-$7.80 in 2025-Q4 to $8.35-$8.55 in 2026-Q1. The trajectory shows an upward revision in guidance, indicating progress towards this priority.
EPS guidance increased to $8.35-$8.5510%CEO/CFO:“The Company is increasing its full year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55.”Multiple sourcesSource dated 2026-04-21Stated 2 of last 8 quartersFirst seen 2026-05-04Show history (2)
- 2026-Q1Multiple sources
“The Company is increasing its full year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55.”
- 2025-Q4Multiple sources
“The Company is maintaining its full year adjusted diluted net earnings per common share guidance range of $7.70 to $7.80.”
- #2
Grow core revenue 3% to 6%
GrowthNew since 2026-05-04Danaher aims to achieve a 3% to 6% year-over-year increase in non-GAAP core revenue.
BehindStated in 3 of last 3 quarters. Revenue decreased from $6.09B in 2025-Q4 to $5.74B in 2026-Q1, indicating limited progress towards the 3% to 6% growth target. The recurring focus on this priority has yet to translate into substantive revenue growth.
10%CEO/CFO:“The Company continues to expect that non-GAAP core revenue will increase in the 3% to 6% range year-over-year.”Multiple sourcesSource dated 2026-04-21Stated 3 of last 8 quartersFirst seen 2026-05-04Show history (3)
- 2026-Q1Multiple sources
“The Company continues to expect that non-GAAP core revenue will increase in the 3% to 6% range year-over-year.”
- 2025-Q4Multiple sources
“For full year 2026, the Company expects that non-GAAP core revenue will increase in the 3% to 6% range year-over-year.”
- 2025-Q3Multiple sources
“Non-GAAP core revenue will grow low-single digits year-over-year for the full year 2025.”
- #3
Announce share buyback
Capital allocationNew since 2026-05-04Danaher announced a share buyback as part of its capital allocation strategy.
MixedNewly stated in 2026-Q1. The announcement of a share buyback on April 29, 2026, marks a step in Danaher's capital allocation strategy. However, without specific buyback amounts or execution details, the impact remains to be seen.
40%CEO/CFO:“Danaher announced a share buyback on April 29, 2026.”Multiple sourcesSource dated 2026-04-29Stated 1 of last 8 quartersFirst seen 2026-05-04Show history (1)
- 2026-Q1Multiple sources
“Danaher announced a share buyback on April 29, 2026.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks more expensive than peers.
Cheaper than its own typical valuation.
P/E over the last 5 years
71 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
DHR Danaher Corporation | +13 | fair | moderate |
LLY Lilly (Eli) | +21 | full | moderate |
JNJ Johnson & Johnson | +18 | full | low |
ABBV AbbVie | +12 | fair | low |
UNH UnitedHealth Group | +24 | fair | elevated |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If health_care sector trend rises from +0.06 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently NEW as of 2026-04-21)+4.0 pts
- If next-quarter guidance is cut (currently NEW as of 2026-04-21)-8.0 pts
- If labor state reverses from -0.31 (negative) to +0.31 (positive)-6.8 pts
- If health_care sector trend falls from +0.06 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-05-071d agoItem 5.02
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in
executive changeneutralscore 55 - 2026-04-299d agoItem 1.01
Entry into a Material Definitive Agreement On April 29, 2026, Danaher Corporation (“Danaher”) issued € 500,000,000 aggregate principal amount of Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), € 750,000,000 aggregate principal amount of 3.250% Senior Notes due 2030 (the “2030 Notes”), € 750,000,000 aggregate principal amount of 3.625% Senior Notes due 2034 (the “2034 Notes”) and € 1,000,000,000 aggregate principal amount of 4.000% Senior Notes due 2038 (the “2038 Notes” and,…
capital allocationpositivescore 53 - 2026-04-2018d agoItem 2.02
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 21, 2026, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended March 27, 2026. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
earnings preannouncementneutralscore 43 - 2026-04-1721d agoItem 1.01
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT 364-Day Revolving Credit Facility On April 16, 2026, Danaher Corporation (“Danaher”) entered into a new $5.0 billion 364-day revolving credit facility (the “Credit Facility”) with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto. The Credit Facility expires on April 15, 2027 (the “Scheduled Termination Date”). Danaher may elect, upon the payment of a fee equal to 0.50% of the principal amount…
capital allocationneutralscore 40 - 2026-04-1721d agoItem 2.03
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT The information set forth under
capital allocationnegativescore 32
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.